1. Risk of Recurrent Cardiac Events After Onset of Menopause in Women With Congenital Long-QT Syndrome Types 1 and 2Clinical Perspective
by Jonathan Buber, Jehu Mathew, Arthur J. Moss, W. Jackson Hall, Alon Barsheshet, Scott McNitt, Jennifer L. Robinson, Wojciech Zareba, Michael J. Ackerman, Elizabeth S. Kaufman, David Luria, Michael Eldar, Jeffrey A. Towbin, Michael Vincent, and Ilan Goldenberg
Circulation
Volume 123(24):
June 21, 2011
Copyright © American Heart Association, Inc. All rights reserved.

2. Rate (per 100 patient-years) of cardiac events of any type (comprising syncope, aborted cardiac arrest, or sudden cardiac death) during follow-up among LQT1 and LQT2 study subjects by menopausal period.
Rate (per 100 patient-years) of cardiac events of any type (comprising syncope, aborted cardiac arrest, or sudden cardiac death) during follow-up among LQT1 and LQT2 study subjects by menopausal period. Event rates per 100 person-years among LQT1 and LQT2 women were calculated by dividing the number of events during each menopausal period by the follow-up time in the same period and multiplying the result by 100.
Jonathan Buber et al. Circulation. 2011;123:
Copyright © American Heart Association, Inc. All rights reserved.

3. Rate (per 100 patient-years) of cardiac events of any type (comprising syncope, aborted cardiac arrest, or sudden cardiac death) during follow-up among LQT1 and LQT2 study subjects by menopausal period and by estrogen therapy during the postmenopausal period.
Rate (per 100 patient-years) of cardiac events of any type (comprising syncope, aborted cardiac arrest, or sudden cardiac death) during follow-up among LQT1 and LQT2 study subjects by menopausal period and by estrogen therapy during the postmenopausal period. Event rates per 100 person-years among LQT1 and LQT2 women were calculated by dividing the number of events each category by the follow-up time in the same category and multiplying the result by 100.
Jonathan Buber et al. Circulation. 2011;123:
Copyright © American Heart Association, Inc. All rights reserved.